TLR 7/8: Covaxin’s Key molecule developed by Indian lab
Part of: GS Prelims and GS- III – Sci & Tech; Achievements of Indians
In news:
The Indian Institute of Chemical Technology (IICT), a Council for Scientific and Industrial Research (CSIR) lab helped in the development of key molecule for COVAXIN.
Key takeaways
Covaxin is the indigenous vaccine developed by the Bharat Biotech International Limited.
It is a highly purified, whole virion, inactivated SARS-Cov-2.
It has been formulated with ‘Algel-IMDG’, which contains chemically absorbed TLR7/8 as an adjuvant onto aluminium hydroxide gel to generate the requisite type of immune responses without damaging the body.
